White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

Recruiting

3 1 1 1
Investigated Drugs:
Study on Rosuvastatin and Placebo for Patients with Statin Intolerance and High Cardiovascular Risk

Recruiting

3 1
Investigated Drugs:
- Atorvastatin Calcium
- Rosuvastatin Calcium
Study on the Early Effects of Ketamine and Venlafaxine for Hospitalized Patients with Severe Major Depression

Recruiting

3 1 1 1
Investigated Drugs:
Study on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A

Recruiting

3 1 1 1
Investigated Diseases:
- Factor VIII deficiency
Investigated Drugs:
- Emicizumab
Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

Recruiting

2 1 1
Investigated Diseases:
- Hypertrophic cardiomyopathy
Investigated Drugs:
- Aficamten
+6
Study of Durvalumab alone and in combination with Tremelimumab in children with advanced solid tumors and blood cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Tremelimumab
- Durvalumab
Study on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis

Recruiting

3 1 1
Investigated Diseases:
- Multiple sclerosis
- Multiple sclerosis relapse
Investigated Drugs:
- Ozanimod Hydrochloride
Study on Self-Administration of Elranatamab for Patients with Multiple Myeloma at Home

Recruiting

2 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
- Elranatamab
Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

Recruiting

2 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Zasocitinib
+8
Study on Rituximab for Preventing Epstein-Barr Virus Infection and Lymphoproliferative Disorders in EBV-Negative Kidney Transplant Patients

Recruiting

3 1 1 1
Investigated Diseases:
- Epstein-Barr virus infection
- Renal transplant
Investigated Drugs:
- Rituximab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies